The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 143.80
Bid: 142.80
Ask: 143.20
Change: 1.40 (0.98%)
Spread: 0.40 (0.28%)
Open: 139.00
High: 144.60
Low: 139.00
Prev. Close: 142.40
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre Stabilisation Notice

6 Feb 2024 10:59

RNS Number : 1946C
HSBC Bank plc
06 February 2024
 

6th February 2024

 

Kier Group plc

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

Kier Group plc

Guarantor (if any):

na

Aggregate nominal amount:

GBP 250,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc, Natwest Markets, Lloyds Bank Corporate Markets, IMI - Intesa Sanpaolo

Stabilisation period expected to start on:

8th February 2024

Stabilisation period expected to end no later than:

15th March 2024

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAKZGGZGVVGDZM
Date   Source Headline
18th Jan 20183:59 pmRNSDirector/PDMR Shareholding
18th Jan 20189:19 amRNSNotification of change of Director's details
15th Jan 20188:27 amRNSJoint Ventures with Carillion PLC
2nd Jan 201810:29 amRNSBlock listing Interim Review
19th Dec 20172:40 pmRNSDirector/PDMR Shareholding
19th Dec 201711:36 amRNSHolding(s) in Company
15th Dec 20174:01 pmRNSDirector/PDMR Shareholding
15th Dec 201712:20 pmRNSAdditional Listing
14th Dec 20172:05 pmRNSDirector/PDMR Shareholding
6th Dec 20174:41 pmRNSDirector/PDMR Shareholding
5th Dec 201710:47 amRNSDirector/PDMR Shareholding
4th Dec 20175:35 pmRNSDirector/PDMR Shareholding
1st Dec 201711:17 amRNSHolding(s) in Company
30th Nov 20179:28 amRNSHolding(s) in Company
22nd Nov 20174:44 pmRNSDirector/PDMR Shareholding
21st Nov 20173:49 pmRNSDirector/PDMR Shareholding
20th Nov 201711:56 amRNSDirector/PDMR Shareholding
17th Nov 20173:35 pmRNSResult of AGM
17th Nov 20172:44 pmRNSDirector/PDMR Shareholding
17th Nov 201710:01 amRNSDirector/PDMR Shareholding
17th Nov 20177:00 amRNSAGM Trading Update
14th Nov 20177:00 amRNSKier appointed to ESFA £8bn construction framework
13th Nov 20179:50 amRNSHolding(s) in Company
2nd Nov 201710:13 amRNSDirector/PDMR Shareholding
1st Nov 20171:18 pmRNSTotal Voting Rights
25th Oct 20174:53 pmRNSDirector/PDMR Shareholding
25th Oct 20171:21 pmRNSDirector/PDMR Shareholding
24th Oct 20174:04 pmRNSDirector/PDMR Shareholding
23rd Oct 20174:59 pmRNSDirector/PDMR Shareholding
20th Oct 20173:09 pmRNSDirector/PDMR Shareholding
19th Oct 20173:29 pmRNSDirector/PDMR Shareholding
19th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 201710:47 amRNSAdditional Listing
13th Oct 20172:47 pmRNSDirector/PDMR Shareholding
11th Oct 20175:14 pmRNSAnnual Financial Report
2nd Oct 20173:00 pmRNSDirector/PDMR Shareholding
2nd Oct 201710:28 amRNSTotal Voting Rights
29th Sep 20174:35 pmRNSDirector/PDMR Shareholding
28th Sep 20174:49 pmRNSDirector/PDMR Shareholding
22nd Sep 201710:50 amRNSDirector/PDMR Shareholding
21st Sep 20174:42 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSFinal Results
19th Sep 201710:02 amRNSHolding(s) in Company
11th Sep 20171:59 pmRNSHolding(s) in Company
1st Sep 201712:20 pmRNSTotal Voting Rights
23rd Aug 20173:44 pmRNSHolding(s) in Company
21st Aug 20172:46 pmRNSDirector/PDMR Shareholding
18th Aug 201712:44 pmRNSNotification of change of Director's details
1st Aug 201712:08 pmRNSTotal Voting Rights
1st Aug 20177:00 amRNSDirectorate Change Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.